HOME >> BIOLOGY >> NEWS
Women pregnant with girls experience more severe asthma symptoms

Women with asthma who are carrying a female fetus are more likely to experience worse asthma symptoms than asthmatic women carrying a male fetus, researchers at Yale School of Medicine report in the February issue of American Journal of Epidemiology.

"This is one of the first and largest studies to investigate the effect of fetal sex on the severity of the mother's asthma, and one of the largest to investigate the effect of fetal sex on any disease of the mother," said senior author Michael B. Bracken, Susan Dwight Bliss Professor of Epidemiology in the Department of Epidemiology and Public Health at Yale School of Medicine.

The researchers monitored 702 pregnant women throughout southern New England who were trained to assess their lung function for 10-day intervals at selected points in pregnancy. Lung function and a large number of other factors that might influence severity of the mother's asthma were recorded automatically.

Asthma worsened in mothers with either male or female fetuses until about 30 weeks gestation, after which there was an improvement in lung function. However, throughout pregnancy, mothers with a male fetus had 10 percent better lung function.

"This difference due to sex is potentially important but needs to be placed in the context of other factors which have a greater impact on the severity of mother's asthma, including inadequate medical management of asthma symptoms, and whether the mother was a smoker or not," said Bracken, who also co-directs the Yale Center for Perinatal, Pediatric and Environmental Epidemiology.

The authors speculate that testosterone, secreted by the male fetuses, may relax the mother's bronchial tissue and inhibit response to histamines. Other sex-specific factors excreted by female fetuses may aggravate inflammation in mothers. Bracken said more research is needed to test these hypotheses.

Asthma is one of the most common diseases associated with pregnancy. An up
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
2-Feb-2006


Page: 1 2

Related biology news :

1. Women up to age 30 at risk for bone loss, study finds
2. MBL scientist Julie Huber receives 2007 LOral USA Fellowship for Women in Science
3. Brandeis and Brigham and Womens Hospital license technology for Gauchers to Amicus Therapeutics
4. Women in polluted areas at higher risk of cardiovascular disease
5. Womens skin tone influences perception of beauty, health and age
6. Womens math performance affected by theories on sex differences: UBC researchers
7. Womens Bioethics Project unveils The Scientist & the Ethicist podcast series
8. Weizmann Women & Science Award presented to Dr. Mary-Claire King
9. Mary-Claire King to receive the 2006 Weizmann Women & Science Award
10. Womens health findings presented at national conference
11. Womens bioethics project receives grant from Ford Foundation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Women pregnant with girls experience more severe asthma symptoms

(Date:5/18/2015)... , May 18, 2015 Fingerprint Cards ... FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one if its ... until and including Q3 2015 and the sensors will be ... Communicated order values for 2015 hereby amount to 740 MSEK ... 2015 of 140 MSEK and a number of smaller orders ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
(Date:5/5/2015)... Conn. , May 5, 2015, NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, reminds ... Company,s Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS ... May 5-7, 2015. The three-day conference is ... David is speaking in is themed Global Fraud: Where ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... 2015 Veolia’s environmental monitoring technology ... American distribution agreement with VWR to distribute TECTA™ ... more than 160 years of experience, VWR, a ... laboratory and production facilities, has cultivated a value ... services to enable science. Endetec’s TECTA™ B16, ...
(Date:5/20/2015)... MA (PRWEB) May 20, 2015 This ... history, especially for lawns. US Patented Pearl’s Premium ... for lawns around the country that are coming out ... that addresses a number of major global concerns related ... the “non-grass” grass – the alternative to the standard, ...
(Date:5/20/2015)... -- Health eCareers, the healthcare industry,s online career hub, ... looking for the flexibility of short-term assignments through ... tool dedicated exclusively to temporary and shift work ... employers to quickly find and hire experienced professionals ... other temporary positions, eliminating the time and resources ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3
Cached News: